Guardant Health Inc (NASDAQ: GH) on Monday, plunged -6.57% from the previous trading day, before settling in for the closing price of $18.26. Within the past 52 weeks, GH’s price has moved between $16.92 and $41.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 49.27% over the last five years. The company achieved an average annual earnings per share of 23.50%. With a float of $115.88 million, this company’s outstanding shares have now reached $121.63 million.
The firm has a total of 1779 workers. Let’s measure their productivity.
Guardant Health Inc (GH) Insider Activity
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Guardant Health Inc is 4.79%, while institutional ownership is 94.15%. The most recent insider transaction that took place on Mar 18 ’24, was worth 38,963. In this transaction Chief Information Officer of this company bought 2,187 shares at a rate of $17.82, taking the stock ownership to the 12,722 shares. Before that another transaction happened on Mar 04 ’24, when Company’s Director sold 100 for $19.05, making the entire transaction worth $1,905. This insider now owns 4,521 shares in total.
Guardant Health Inc (GH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 23.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.80% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Guardant Health Inc (GH) is currently performing well based on its current performance indicators. A quick ratio of 6.24 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.28, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.02 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Analysing the last 5-days average volume posted by the [Guardant Health Inc, GH], we can find that recorded value of 1.79 million was lower than the volume posted last year of 1.9 million. As of the previous 9 days, the stock’s Stochastic %D was 12.84%. Additionally, its Average True Range was 1.24.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 1.08%, which indicates a significant decrease from 2.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.62% in the past 14 days, which was higher than the 61.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.71, while its 200-day Moving Average is $27.28. Now, the first resistance to watch is $18.03. This is followed by the second major resistance level at $18.99. The third major resistance level sits at $19.54. If the price goes on to break the first support level at $16.52, it is likely to go to the next support level at $15.97. Should the price break the second support level, the third support level stands at $15.01.
Guardant Health Inc (NASDAQ: GH) Key Stats
Market capitalization of the company is 2.08 billion based on 121,713K outstanding shares. Right now, sales total 563,950 K and income totals -479,450 K. The company made 155,050 K in profit during its latest quarter, and -187,040 K in sales during its previous quarter.
